» Articles » PMID: 31007761

Sarcoidosis in the Middle East

Overview
Journal Ann Thorac Med
Specialty Pulmonary Medicine
Date 2019 Apr 23
PMID 31007761
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis, a systemic granulomatous disease of unknown cause, has been described worldwide and in all populations with notable differences in clinical characteristics, organ involvement, disease severity, and prognosis among different ethnic and racial groups. While the exact prevalence of sarcoidosis in the Middle East is unknown, studies from various countries in the region have reported the clinical characteristics of affected patients, along with a few anecdotal reports. A search of the MEDLINE and Google Scholar databases was conducted for relevant English-language articles using the terms "sarcoidosis" and "Middle East" or "sarcoidosis" and "Arabs." Subsequently, the names of individual countries were used as search terms, replacing "Middle East." Overall, the clinical picture of patients with sarcoidosis in the Middle East is similar to that reported elsewhere; for example, the disease was more frequent among females and respiratory complaints were the predominant symptoms. Within the region, most patients from Oman were older and female, with arthralgia, hypercalcemia, and eye involvement being more common. Constitutional symptoms were frequent, especially among patients from Iran. Cough was more common among patients from Kuwait and Iran, while dyspnea was the predominant symptom for Saudi patients. Erythema nodosum was more common in the Turkish population. Clustering was seen in patients with Stage I and II of the disease in all countries except Oman. Apart from those in Iran, the prognosis of most patients from the Middle East was excellent.

Citing Articles

First insights and future research perspectives from the sarcoidosis registry at the Medical University of Vienna.

Guttmann-Ducke C, Lutnik M, Gysan M, Sarova P, Milacek C, Bal C Sci Rep. 2025; 15(1):8644.

PMID: 40082706 PMC: 11906772. DOI: 10.1038/s41598-025-93708-9.


Elderly sarcoidosis in Japan.

Masumoto N, Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T J Int Med Res. 2022; 50(12):3000605221142705.

PMID: 36562117 PMC: 9793039. DOI: 10.1177/03000605221142705.


The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients.

Abedini A, Naderi Z, Kiani A, Marjani M, Mortaz E, Ghorbani F J Res Med Sci. 2020; 25:24.

PMID: 32419781 PMC: 7213005. DOI: 10.4103/jrms.JRMS_74_19.

References
1.
Uthman I, Bizri A, Shabb N, Khury M, Khalifeh M . Peritoneal sarcoidosis: case report and review of the literature. Semin Arthritis Rheum. 1999; 28(5):351-4. DOI: 10.1016/s0049-0172(99)80020-1. View

2.
Samman Y, Ibrahim M, Wali S . Sarcoidosis in the western region of Saudi Arabia. Sarcoidosis Vasc Diffuse Lung Dis. 1999; 16(2):215-8. View

3.
Costabel U, Hunninghake G . ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999; 14(4):735-7. DOI: 10.1034/j.1399-3003.1999.14d02.x. View

4.
Baughman R, Teirstein A, Judson M, Rossman M, Yeager Jr H, Bresnitz E . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1885-9. DOI: 10.1164/ajrccm.164.10.2104046. View

5.
Rybicki B, Iannuzzi M, Frederick M, Thompson B, Rossman M, Bresnitz E . Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001; 164(11):2085-91. DOI: 10.1164/ajrccm.164.11.2106001. View